[1]
“Comparative cost-effectiveness of intralesional meglumine antimoniate alone versus cryotherapy plus intralesional meglumine antimoniate in cutaneous leishmaniasis: Experience from a high capacity dermatology centre”, J Pak Assoc Dermatol, vol. 32, no. 2, pp. 353–359, Jun. 2022, doi: 10.66344/jpad.v32i2.1956.